These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 20933455)

  • 1. Microflow of fluorescently labelled red blood cells in tumours expressing single isoforms of VEGF and their response to vascular targeting agents.
    Akerman S; Reyes-Aldasoro CC; Fisher M; Pettyjohn KL; Björndahl MA; Evans H; Tozer GM
    Med Eng Phys; 2011 Sep; 33(7):805-9. PubMed ID: 20933455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of soluble or matrix-bound isoforms of vascular endothelial growth factor-A on tumor response to vascular-targeted strategies.
    Akerman S; Fisher M; Daniel RA; Lefley D; Reyes-Aldasoro CC; Lunt SJ; Harris S; Bjorndahl M; Williams LJ; Evans H; Barber PR; Prise VE; Vojnovic B; Kanthou C; Tozer GM
    Int J Cancer; 2013 Dec; 133(11):2563-76. PubMed ID: 23712501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood vessel maturation and response to vascular-disrupting therapy in single vascular endothelial growth factor-A isoform-producing tumors.
    Tozer GM; Akerman S; Cross NA; Barber PR; Björndahl MA; Greco O; Harris S; Hill SA; Honess DJ; Ireson CR; Pettyjohn KL; Prise VE; Reyes-Aldasoro CC; Ruhrberg C; Shima DT; Kanthou C
    Cancer Res; 2008 Apr; 68(7):2301-11. PubMed ID: 18381437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumour cells expressing single VEGF isoforms display distinct growth, survival and migration characteristics.
    Kanthou C; Dachs GU; Lefley DV; Steele AJ; Coralli-Foxon C; Harris S; Greco O; Dos Santos SA; Reyes-Aldasoro CC; English WR; Tozer GM
    PLoS One; 2014; 9(8):e104015. PubMed ID: 25119572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of the vascular endothelial growth factor isoforms in retinal angiogenesis and DiGeorge syndrome.
    Stalmans I
    Verh K Acad Geneeskd Belg; 2005; 67(4):229-76. PubMed ID: 16334858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measuring the velocity of fluorescently labelled red blood cells with a keyhole tracking algorithm.
    Reyes-Aldasoro CC; Akerman S; Tozer GM
    J Microsc; 2008 Jan; 229(Pt 1):162-73. PubMed ID: 18173654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential expression of VEGF isoforms in mouse during development and in the adult.
    Ng YS; Rohan R; Sunday ME; Demello DE; D'Amore PA
    Dev Dyn; 2001 Feb; 220(2):112-21. PubMed ID: 11169844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcriptional regulation of vascular endothelial growth factor expression in epithelial and stromal cells during mouse mammary gland development.
    Hovey RC; Goldhar AS; Baffi J; Vonderhaar BK
    Mol Endocrinol; 2001 May; 15(5):819-31. PubMed ID: 11328861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The antiangiogenic agents SU5416 and SU6668 increase the antitumor effects of fractionated irradiation.
    Ning S; Laird D; Cherrington JM; Knox SJ
    Radiat Res; 2002 Jan; 157(1):45-51. PubMed ID: 11754641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PTK787/ZK222584, a tyrosine kinase inhibitor of vascular endothelial growth factor receptor, reduces uptake of the contrast agent GdDOTA by murine orthotopic B16/BL6 melanoma tumours and inhibits their growth in vivo.
    Rudin M; McSheehy PM; Allegrini PR; Rausch M; Baumann D; Becquet M; Brecht K; Brueggen J; Ferretti S; Schaeffer F; Schnell C; Wood J
    NMR Biomed; 2005 Aug; 18(5):308-21. PubMed ID: 15918178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measuring VEGF-Flk-1 activity and consequences of VEGF-Flk-1 targeting in vivo using intravital microscopy: clinical applications.
    Vajkoczy P; Thurnher A; Hirth KP; Schilling L; Schmiedek P; Ullrich A; Menger MD
    Oncologist; 2000; 5 Suppl 1():16-9. PubMed ID: 10804086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Do anti-angiogenic VEGF (VEGFxxxb) isoforms exist? A cautionary tale.
    Harris S; Craze M; Newton J; Fisher M; Shima DT; Tozer GM; Kanthou C
    PLoS One; 2012; 7(5):e35231. PubMed ID: 22567098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Balance of pro- versus anti-angiogenic splice isoforms of vascular endothelial growth factor as a regulator of neuroblastoma growth.
    Peiris-Pagès M; Harper SJ; Bates DO; Ramani P
    J Pathol; 2010 Oct; 222(2):138-47. PubMed ID: 20662003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. VEGF and angiogenesis in acute and chronic MOG((35-55)) peptide induced EAE.
    Roscoe WA; Welsh ME; Carter DE; Karlik SJ
    J Neuroimmunol; 2009 Apr; 209(1-2):6-15. PubMed ID: 19233483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of vascular endothelial growth factor-associated tyrosine kinase activity with SU5416 blocks sprouting in the microvascular endothelial cell spheroid model of angiogenesis.
    Haspel HC; Scicli GM; McMahon G; Scicli AG
    Microvasc Res; 2002 May; 63(3):304-15. PubMed ID: 11969307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different effects of glucose starvation on expression and stability of VEGF mRNA isoforms in murine ovarian cancer cells.
    Zhang L; Conejo-Garcia JR; Yang N; Huang W; Mohamed-Hadley A; Yao W; Benencia F; Coukos G
    Biochem Biophys Res Commun; 2002 Apr; 292(4):860-8. PubMed ID: 11944893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiogenic and astroglial responses to vascular endothelial growth factor administration in adult rat brain.
    Krum JM; Mani N; Rosenstein JM
    Neuroscience; 2002; 110(4):589-604. PubMed ID: 11934468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-vascular agent Combretastatin A-4-P modulates hypoxia inducible factor-1 and gene expression.
    Dachs GU; Steele AJ; Coralli C; Kanthou C; Brooks AC; Gunningham SP; Currie MJ; Watson AI; Robinson BA; Tozer GM
    BMC Cancer; 2006 Dec; 6():280. PubMed ID: 17156434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impaired angiogenesis and endochondral bone formation in mice lacking the vascular endothelial growth factor isoforms VEGF164 and VEGF188.
    Maes C; Carmeliet P; Moermans K; Stockmans I; Smets N; Collen D; Bouillon R; Carmeliet G
    Mech Dev; 2002 Feb; 111(1-2):61-73. PubMed ID: 11804779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PTK787/ZK 222584, a specific vascular endothelial growth factor-receptor tyrosine kinase inhibitor, affects the anatomy of the tumor vascular bed and the functional vascular properties as detected by dynamic enhanced magnetic resonance imaging.
    Drevs J; Müller-Driver R; Wittig C; Fuxius S; Esser N; Hugenschmidt H; Konerding MA; Allegrini PR; Wood J; Hennig J; Unger C; Marmé D
    Cancer Res; 2002 Jul; 62(14):4015-22. PubMed ID: 12124335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.